HOME >> BIOLOGY >> NEWS
GroPep announces US FDA approval of biopharmaceutical that uses its cell culture product

GroPep Limited (ASX: GRO) has today announced that a seventh biopharmaceutical product that uses the Company's Cell Culture Products in its manufacturing process, has obtained regulatory approval by the Food and Drug Administration (FDA) in the United States.

An application to market the product in the European Union has also been submitted, for which approval is expected in 2006.

Confidentiality agreements prevent GroPep from naming the specific product or company.

While this approval is not likely to generate significant revenue growth for GroPep, CEO Mr Bob Finder said that the approval is further evidence of the growing international recognition of the superiority of GroPep's Cell Culture Products in the manufacturing of certain biopharmaceutical products.


'"/>

Contact: Tony Mitchell
investorrelations@gropep.com.au
61-8-8354-7700
Research Australia
2-Jun-2005


Page: 1

Related biology news :

1. GroPep infertility data presented at US meeting
2. GroPep announces Japanese approval of biopharmaceutical that uses its cell culture products
3. Almac Diagnostics announces pioneering genetic research on ductal carcinoma in situ
4. ESA announces 2007 award recipients
5. President Bush announces 2005 and 2006 Laureates of National Medals of Science and Technology
6. Conservation Leadership Program announces 2007 awardees
7. ACMG Foundation announces 2007-2008 Luminex/ACMGF award recipient
8. Revolutionary global environment fund announces $50M expansion
9. Biovest announces interim blinded data of fast-tracked pivotal Phase 3 clinical trial of BiovaxID
10. Cell Press announces new partnership with the American Society of Human Genetics
11. ChemGenex announces publication confirming activity of Ceflatonin in T315I-Positive CML

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/15/2019)... ... 15, 2019 , ... Serialization deadlines in the US and ... and aggregation becomes fully applied in the United States in 2023, pharmaceutical companies ... Until now, most regulations?including the Drug Supply Chain Security Act (DSCSA)?have required minimal ...
(Date:8/14/2019)... ... ... Join Jonathan Riek, PhD, VP, Musculoskeletal & Metabolic Imaging, BioTel Research ... EDT to learn about two common imaging methods in NAFLD/NASH to aid with early ... diffuse liver disease, with a worldwide prevalence of 20-46 percent. NAFLD can be subdivided ...
(Date:8/14/2019)... ... August 13, 2019 , ... Dr. Julie Reck of Veterinary Medical Center of ... patients. Her first stem cell patient, her own geriatric Australian Shepherd, Simon, was treated ... Reck, Simon wanted to play but his body was weak, and he struggled to play ...
Breaking Biology News(10 mins):
(Date:7/19/2019)... ... July 18, 2019 , ... World renowned ... be joining forces with California-based charity Coalition Duchenne for its 9th Annual Expedition ... raises awareness and funding for Duchenne muscular dystrophy and was founded by Sabahan ...
(Date:7/17/2019)... ... July 16, 2019 , ... ... the development and manufacturing of Zolgensma® (onasemnogene abeparvovec-xioi), an AveXis gene therapy ... Novartis company, will have dedicated manufacturing space at the new, state-of-the-art commercial ...
(Date:7/11/2019)... , ... July 11, 2019 , ... At the most ... complimentary regenerative therapies to eight military Veterans under the R3 Heroes Program. The Veterans ... , The R3 Heroes Program allow anyone to nominate a military Veteran, teacher or ...
(Date:7/9/2019)... ... July 08, 2019 , ... Balluff ... Indicator was recognized as the 2019 Innovative Product of the Year which highlights ... awards were during Sensors Expo & Conference 2019, held this week ...
Breaking Biology Technology:
Cached News: